To enhance service speed and avoid tariff delays, we've opened a US warehouse. All US orders ship directly from our US facility.
| Cat. No. | Product Name | Field of Application | Chemical Structure |
|---|---|---|---|
| DC43817 | AMG-51 |
A selective inhibitor of c-Met kinase
More description
|
|
| DC43816 | Mogroside IIe |
|
|
| DC43815 | Isogambogenic acid |
|
|
| DC43814 | Cerebroside B |
|
|
| DC43813 | M8-B |
Selective and potent antagonist of the transient receptor potential melastatin-8 (TRPM8) channel
More description
|
|
| DC43811 | Alismol |
|
|
| DC43809 | S(-)-Cyanopindolol hemifumarate |
5-HT1A/1B serotonin receptor antagonist; β3-adrenoceptor antagonist
More description
|
|
| DC43808 | SV-156 |
Highly selective D2 dopamine receptor antagonist
More description
|
|
| DC43807 | Isoneochamaejasmine A |
|
|
| DC43806 | 5-Hydroxy-1,7-diphenyl-6-hepten-3-one |
|
|
| DC43805 | A-839977 |
Potent P2X7 antagonist blocking BzATP-evoked calcium influx
More description
|
|
| DC43803 | threo-Guaiacylglycerol beta-coniferyl ether |
|
|
| DC43802 | AM374 |
Potent in vitro and in vivo inhibitor of fatty acid amide hydrolase (FAAH)
More description
|
|
| DC43799 | PC170942 |
Novel Inhibitor of Bacterial Cytokinesis, inhibiting FtsZ
More description
|
|
| DC43796 | Noremopamil |
Calcium entry blocker, also being used as the precursor for radiolabelling emopamil
More description
|
|
| DC43795 | Yuexiandajisu D |
|
|
| DC43794 | Chamaejasmenin D |
|
|
| DC43793 | EACC |
Novel reversible inhibitor of autophagic flux, preventing Stx17 loading onto autophagosomes and blocking autophagosome-lysosome fusion without any effect on lysosomal properties or on endocytosis mediated degradation of EGF receptor
More description
|
|
| DC43791 | Methylprednisolone Aceponate |
Glucocorticosteroid; Antipsoriatic agent
More description
|
|
| DC43790 | 5,8-Epidioxyergosta-6,9(11),22-trien-3-ol |
|
|
| DC43789 | JW-74 |
Novel inhibitor of canonical Wnt signaling
More description
|
|
| DC43787 | Cogentin |
An anticholinergic drug used in patients to reduce the side effects of antipsychotic treatment and a second-line drug for the treatment of Parkinson's disease
More description
|
|
| DC43786 | Xylopropamine Hydrobromide |
Anti-inflammatory and analgesic agent
More description
|
|
| DC43785 | Infree |
Prodrug of indomethacin, nonsteroidal anti-inflammatory drug (NSAID) and disease-modifying anti-rheumatic drug (DMARD)
More description
|
|
| DC43784 | Ethaverine Hydrobromide |
Inhibitor of the parasympathetic nervous system actions
More description
|
|
| DC43783 | Caffeic anhydride |
|
|
| DC43782 | CID-4785700 |
Novel specific Inhibitor of histone acetyltransferase
More description
|
|
| DC43781 | ML031 |
The first small molecule, S1P2 selective agonist reported
More description
|
|
| DC43779 | TG41 |
Novel positive modulator of GABAA receptors
More description
|
|
| DC43776 | Calceolarioside A |
|